Vanguard Group Inc Novo Cure LTD Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Vanguard Group Inc holds 11,796,109 shares of NVCR stock, worth $215 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,796,109

Previous 11,844,608 0.41%

Holding current value

$215 Million

Previous $185 Million 89.88%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$14.54 - $33.41 $705,175 - $1.62 Million	-48,499 Reduced 0.41%	11,796,109 $352 Million
Q3 2024 Nov 13, 2024	BUY	$15.61 - $23.34 $11.2 Million - $16.7 Million	717,243 Added 6.45%	11,844,608 $185 Million
Q2 2024 Aug 13, 2024	BUY	$11.83 - $24.05 $13.1 Million - $26.5 Million	1,103,384 Added 11.01%	11,127,365 $191 Million
Q1 2024 May 10, 2024	BUY	$12.42 - $17.29 $3.29 Million - $4.58 Million	264,883 Added 2.71%	10,023,981 $157 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $1.36 Million - $1.93 Million	122,105 Added 1.27%	9,759,098 $146 Million
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $439,166 - $1.15 Million	-27,193 Reduced 0.28%	9,636,993 $156 Million
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $2.17 Million - $4.44 Million	-53,787 Reduced 0.55%	9,664,186 $401 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $9.63 Million - $20.3 Million	170,637 Added 1.79%	9,717,973 $584 Million
Q4 2022 Feb 10, 2023	BUY	$63.98 - $85.37 $83.7 Million - $112 Million	1,308,501 Added 15.88%	9,547,336 $700 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $8.78 Million - $11.6 Million	129,096 Added 1.59%	8,238,835 $626 Million
Q2 2022 Aug 12, 2022	BUY	$56.6 - $89.9 $6.34 Million - $10.1 Million	112,051 Added 1.4%	8,109,739 $564 Million
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $6.28 Million - $8.82 Million	104,375 Added 1.32%	7,997,688 $663 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $2.36 Million - $3.84 Million	31,453 Added 0.4%	7,893,313 $593 Million
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $6.13 Million - $10.3 Million	52,737 Added 0.68%	7,861,860 $913 Million
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $1.02 Billion - $1.76 Billion	7,809,123 New	7,809,123 $1.73 Billion

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

75.6M

Call Options Held

1.77M

Put Options Held

538K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.91B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Novo Cure LTD Transaction History